E29, Ms

Technische Daten
Status:In Vitro Diagnostic Use (IVD)
Ig Unterklasse:IgG2a/k
Immunogen:Epithelial membrane antigen (EMA)
Vorbehandlung:ProTaqs® Antigen Enhancer I (Cat. No. 401602092) or ProTaqs® Antigen Enhancer IV (Cat. No. 401602392)
Zelluläre Lokalisation:Cytoplasmic, membranous
Kontrolle:Breast, skin
Change(s) made:Complete revision
EK Distributor €:-
EK Liste €:137
Synonyme:MUC1, polymorphic epithelial mucin, PEM, CD227, EMA, H23AG, KL-6, MAM6, MUC-1, MUC-1/SEC, MUC-1/X, MUC1/ZD, PEMT, PUM, Breast carcinoma associated antigen DF3, CA15.3, Carcinoma associated mucin, CD 227, Episialin, Epithelial membrane antigen, Epithelial mucin tandem repeat sequence, Krebs von den Lungen-6, Peanut reactive urinary mucin, Tumor associated epithelial membrane antigen, Tumor associated mucin
Verfügbar in folgenden Ländern:worldwide

EMA is a glycoprotein that serves a protective function by binding to pathogens and also functions in a cell signaling capacity. This antobody stains many carcinomas, normal and neoplastic cells from various tissues, including mammary epithelium, sweat glands and squamous epithelium. The absence of EMA is also important since negative EMA staining is characteristic for some tumors, including adrenal carcinoma, seminomas, paraganglioma and hepatoma.